FDA Unveils New Drug Compounding Policies
The U.S. Food and Drug Administration on Friday unveiled four guidances that further flesh out oversight policies affecting drug compounders, describing how unapproved products can be manipulated, how adverse events should...To view the full article, register now.
Already a subscriber? Click here to view full article